AzTrials
AzTrials

Heart DiseasePhase 3NCT01561196

Conventional Verses Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia

A Phase 3 study testing arterial catheterisation in people with Heart Disease, run by Marlene A Hansen, Stud.med at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the project is to compare two methods for arterial cannulation. The traditional method with ultrasound guided cannulation. The investigators goal is to improve this procedure to reduce pain and complications. Read more about this study

Who is it for?
Ages 20 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Heart Disease
What is being tested?
arterial catheterisation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteDenmark
Study dates
Feb 2012to Dec 2012
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 20-90 years
  • Fulfill the criteria of an operation
  • Routine need of an arterial needle

Who cannot join

  • Lack of patient consent
  • Ultrasound identified plaques in the radial artery or ultrasound verified positive Allens test or traditional positive Allens test

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Anæstesiologisk-Intensiv afdeling I

    Aarhus, Jylland, 8200

Other trials in Denmark

About this study

Official title: Conventional vs. Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia

The aim of the project is to compare two methods for arterial cannulation. The traditional method with ultrasound guided cannulation. The investigators goal is to improve this procedure to reduce pain and complications.

Read the detailed description

The practice of placing vascular catheters is used many times every day at almost every hospital. It is a safe procedure which generally does not imply problems. Though the procedural optimum aren't reached. The procedure still fails some times and induce complications. When the catheter is placed using the traditional method the pulse is palpated by the operator's fingers. This is only to be done near the hand wrist. In this position the catheter steadiness is fragile but because the pulse can't be sensed more proximal the operator is forced to choose this position. This it though a problem that can be solved by non invasive visualization technology. Ultrasound-guidance for central vascular access is already well-established. However, in recent years ultrasound-guidance for peripheral vascular access has gained popularity too. The evidence of multiple studies demonstrates increased success rate and reduced complication rate with ultrasound compared to blind landmark technique for vascular catheter placement.

In recent years there have been both procedural technique and technology improvements in the field of ultrasound. This has led to the improvement of procedural catheterisation techniques that now can be done by novices with higher attempt success rate than traditional method. One technique that is gaining success is the short-axis-out-of-plane technique (SAX-OOP) with dynamic-needle-tip-tracking (DNTT).Using the ultrasound machine the needle can be placed in a more proximal direction on the forearm and the investigators believe that by the help of the exposed procedure on the monitor many complications can be reduced.

Hypothesis; Firstly the investigators hypothesize that the pain induced by the conventional method inclusive preoperational lidocaine injection will be the same or more intense than using DNTT without local anesthesia. Secondly the investigators hypothesize that the use of DNTT for the placement of the arterial catheter will decrease the time spend, amount of complications (hematoma), the number of pricks, the number of utilized catheters compared to the traditional palpation method. Thirdly the investigators claim that the best anatomical place to put the catheter isn't always corresponding with the spot chosen by palpation, which increase the number of failures.

Conditions
Heart Disease
Being tested
arterial catheterisation
Keywords
arteria cannulation, Ultrasound, pain, complications
Medical subject headings
Heart Diseases, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • arterial catheterisationProcedure or surgery

    Also called ICD10 I95.9

    arterial catheterisation in Arterial Radialis

Study groups in NCT01561196
Study groupRoleWhat they receive
Ultrasound guided arterial cannulationActive comparatorThe arterial needle is placed using ultrasound monitoring for guiding the operator.
Receives: Procedure: arterial catheterisation
Conventional cannulationActive comparatorthe arterial needle is placed using the traditional method and lidocaine. The operator decides where to place the needle in the forearm
Receives: Procedure: arterial catheterisation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain score on visual analog scale

    The primary outcome is the subjective feeling of pain following the two methods.

    Measured: 5 minutes

Secondary outcomes (4)
  1. Time spend on the procedure

    Time will be measured from the point where 1) the operator starts searching for the patients plus or 2) the operator starts examining the patient with the ultrasound machine. The time will be stopped at the time where the catheter is successfully placed.

    Measured: 1 day

  2. Number of utilized needles

    Measured: 1 day

  3. number of pricks

    a prick is defined as eruption of the skin

    Measured: 1 day

  4. number of withdrawals

    a withdrawal is defined as backwards movement of the needle or the needle+catheter.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2012 (estimated)
  2. Study startFeb 2012
  3. Primary completionDec 2012
  4. Study completionDec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01561196
Sponsor's protocol ID
Sloth1
Status last verified
Jan 2013
First submitted
13 Mar 2012
Last updated
31 Jan 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing arterial catheterisation in people with Heart Disease, run by Marlene A Hansen, Stud.med at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain score on visual analog scale (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in